IL264167A - תכשירים ושיטות לטיפול בדמנציה פרונטוטמפורלית - Google Patents

תכשירים ושיטות לטיפול בדמנציה פרונטוטמפורלית

Info

Publication number
IL264167A
IL264167A IL264167A IL26416719A IL264167A IL 264167 A IL264167 A IL 264167A IL 264167 A IL264167 A IL 264167A IL 26416719 A IL26416719 A IL 26416719A IL 264167 A IL264167 A IL 264167A
Authority
IL
Israel
Prior art keywords
compositions
methods
frontotemporal dementia
treating frontotemporal
treating
Prior art date
Application number
IL264167A
Other languages
English (en)
Original Assignee
Annexon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Annexon Inc filed Critical Annexon Inc
Publication of IL264167A publication Critical patent/IL264167A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL264167A 2016-07-19 2019-01-09 תכשירים ושיטות לטיפול בדמנציה פרונטוטמפורלית IL264167A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662364013P 2016-07-19 2016-07-19
PCT/US2017/042846 WO2018017711A1 (en) 2016-07-19 2017-07-19 Compositions and methods for treating frontotemporal dementia

Publications (1)

Publication Number Publication Date
IL264167A true IL264167A (he) 2019-02-28

Family

ID=60992917

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264167A IL264167A (he) 2016-07-19 2019-01-09 תכשירים ושיטות לטיפול בדמנציה פרונטוטמפורלית

Country Status (6)

Country Link
EP (1) EP3487531A4 (he)
AU (1) AU2017299579A1 (he)
CA (1) CA3030872A1 (he)
IL (1) IL264167A (he)
SG (1) SG11201900123TA (he)
WO (1) WO2018017711A1 (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201510316UA (en) 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
FI3380518T3 (fi) * 2015-11-24 2026-05-29 Annexon Inc Antikomplementtitekijä-C1Q:n Fab-fragmentteja ja niiden käyttöjä
CN108159421B (zh) * 2018-02-05 2021-05-18 苏州大学 磷脂酰丝氨酸阻断剂在制备治疗血小板数量减少相关疾病药物中的用途
MX2021004819A (es) * 2018-11-02 2021-06-08 Annexon Inc Composiciones y metodos para tratar lesiones cerebrales.
US20240034775A1 (en) * 2020-05-05 2024-02-01 The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads Compositions and methods for treating epilepsy
AU2021310926A1 (en) 2020-07-23 2023-03-23 Othair Prothena Limited Anti-abeta antibodies
CN117642431B (zh) 2021-07-13 2025-07-15 迈威(美国)生物治疗有限公司 抗c1s抗体和其用途
US12486322B2 (en) 2021-12-13 2025-12-02 Annexon, Inc. Anti-complement factor C1q antibodies with single binding arms and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148330B2 (en) * 2005-12-09 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Modulation of synaptic maintenance
US9480658B2 (en) * 2005-12-09 2016-11-01 The Board Of Trustees Of The Leland Stanford Junior University Modulation of synaptic maintenance
WO2014066744A2 (en) * 2012-10-25 2014-05-01 True North Therapeutics, Inc. Anti-complement c1s antibodies and uses thereof
SG11201510316UA (en) * 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
PL3215527T3 (pl) * 2014-11-05 2025-04-28 Annexon, Inc. Humanizowane przeciwciała przeciwko czynnikowi dopełniacza C1Q i ich zastosowanie

Also Published As

Publication number Publication date
EP3487531A1 (en) 2019-05-29
WO2018017711A1 (en) 2018-01-25
CA3030872A1 (en) 2018-01-25
SG11201900123TA (en) 2019-02-27
EP3487531A4 (en) 2020-03-25
AU2017299579A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
IL251721A0 (he) תכשירים ושיטות לטיפול במחלות של מערכת העצבים המרכזית
SMT202000414T1 (it) Composizioni e metodi per trattare disturbi del snc
ME03749B (me) KOMPOZICIJE I POSTUPCIZA LEČENJE POREMEĆAJA CNS-a
SMT202100113T1 (it) Composizioni e metodi per trattare disturbi del snc
HUE056958T2 (hu) Készítmények és eljárások vérszegénység kezelésére
ZA201805490B (en) Methods and compositions for treating hyperhidrosis
EP3280420A4 (en) Compositions and methods for treating cns disorders
IL250715A0 (he) תכשירים ושיטות לטיפול בהפרעות התרבות
IL251759A0 (he) תכשירים ושיטות לטיפול בנדודי שינה
EP3487531A4 (en) TREATMENT OF FRONTO-TEMPORAL DEMENTIA
ZA201800831B (en) Compositions and methods for treating and preventing neurodegenerative disorders
IL291266A (he) תכשירים ושיטות לטיפול בזיהומים
IL254963A0 (he) תכשירים ושיטות לטיפול באוטיזם
IL250114A0 (he) שיטות והרכבים לטיפול במחלות הקשורות ב-hiv
EP3262065A4 (en) Methods and compositions for treating dystroglycanopathy disorders
SG11201609701UA (en) Pharmaceutical composition for preventing and treating senile dementia and preparation method thereof
EP3104896A4 (en) Compositions and methods for treating liver injury
EP3265097A4 (en) Compositions and methods for treatment and prevention of pyrexia in horses
EP3270919A4 (en) Compositions and methods for treating hepatocellular carcinoma
HK40002800A (en) Methods and compositions for treating melanoma
GB201521083D0 (en) Compositions for treatment and methods thereof
HK1242518A1 (en) Compositions and methods for treating cns disorders